Benzodiazepine Market is Set to Experience a Revolutionary Growth by 2027
Market Highlights
Benzodiazepines (BZD) are a class of psychoactive drugs with sedative,
hypnotic (sleep-inducing), anti-anxiety, anticonvulsant, and muscle relaxant
properties. Benzodiazepines (BZD) are useful in treating anxiety, insomnia,
agitation, seizures, muscle spasms and alcohol withdrawal.
The sale of Benzodiazepine has been declining due to their addictive
side effects and the rise of alternate drugs such as selective serotonin
reuptake inhibitors. However the last few years have witnessed a moderate rise
in the sale
of Benzodiazepines. The lack of efficacy and slow onset of action of
selective serotonin reuptake inhibitors along with the fear of falling back on
first generation anti-psychotic (barbiturate class) drugs have negated any
market moves against Benzodiazepines. Development of short acting
Benzodiazepines is an additional advantage in favour of barbiturates.
Some more restraints hampering the market growth are highly competitive
and segmented market and a shift towards non-pharmacological therapies.
Global Benzodiazepine market:
The Global Benzodiazepine
market has been evaluated as a slowly growing market and it is expected
that the market will reflect sluggish growth figures in future. The global
Benzodiazepine market is expected to grow with CAGR of ~ 1.5% to 2.3 % during the forecast
period.
The major participants of this market are: AstraZeneca plc, Eli
Lilly and Company, GlaxoSmithKline plc, Pfizer, Inc., Sanofi S.A. and
Merck & Co., Inc.
Regional Analysis:
Depending on geographic region, Benzodiazepine market is segmented into
four key regions: Americas, Europe, Asia Pacific, and Middle East & Africa.
Globally developed countries led by North America is the largest market for
Benzodiazepines. Europe is the second-largest market for Benzodiazepines. Asia
pacific region is expected to be fastest growing region in Benzodiazepine
market due to increasing spending on healthcare infrastructure.
Segmentation:
Global Benzodiazepines market has been segmented on the basis of
application which comprises of disposable, reusable and others. On the basis of
application; market is segmented into anxiety, insomnia, agitation, seizures,
muscle spasms and alcohol withdrawal and as anaesthesia supplements. On the
basis of time of action; market is segmented into long acting and short acting
Benzodiazepines.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the
complexity of various industries through our Cooked Research Report (CRR),
Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed
Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market
research and intelligence services to our clients. Our market research studies
by products, services, technologies, applications, end users, and market players
for global, regional, and country level market segments, enable our clients to
see more, know more, and do more, which help to answer all their most important
questions.
In order to stay updated with technology and work process of the
industry, MRFR often plans & conducts meet with the industry experts and
industrial visits for its research analyst members.
Contact:
Akash Anand,
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312
Email: akash.anand@marketresearchfuture.com
Comments
Post a Comment